This downregulation of GAS5 expression contributed to an elevated level of miR-21 and, later, to suppression of expression of PTEN, which finally resulted in HCC cell proliferation, inhibition of cellular apoptosis, and increased resistance to doxorubicin treatment. The gene discussed is PTEN; the disease is hepatocellular carcinoma.